- AU$11.43m
- AU$17.21m
- AU$7.47m
Australia's Rhinomed hits record low after delisting and capital raise announcement
Brief: Rhinomed Formally Applies To ASX Requesting Removal From Official List
Brief: Rhinomed Ltd Seeks Trading Halt
Brief: Rhinomed Says It Is Implementing Measures To Reduce Cash Burn, Including Reduction In Headcount
Brief: Rhinomed Says FY Revenue From Ordinary Activities Down 17.9% To A$7.5 Million
Brief: Rhinomed Says Fy23 Q4 Revenues Of A$2.238M
Brief: Rhinomed Reports 1H Unaudited Recognised Revenue Of A$3.4 Mln
Australia's Rhinomed slumps after flagging delay in Canada COVID test launch
Brief: Rhinomed Says Canadian Market Launch Of Rhinoswab Junior Delayed
Brief: Rhinomed Ltd Establishes A New $2.5 Million Line Of Credit Facility
Brief: Rhinomed Posts Q1 Unaudited Recognised Revenue Of A$1.561Mln
Brief: Rhinomed Posts FY Revenue From Ordinary Activities Of A$9.1 Million
Brief: Rhinomed Says SureScreen Australia Ordered 250,000 Rhinoswab Juniors
Brief: Rhinomed Says Revenue For FY22 Was A$9.1M (Unaudited)
Australia's Rhinomed rises supply deal for nasal swab product
Brief: Rhinomed Says Finalised Exclusive Supply Agreement With Surescreen Australia
Brief: Rhinomed Says QTRLY Revenues A$3.04M, Up 203% Year On Year
Brief: Rhinomed Says It Entered Supply Agreement With BTNX Inc.
Brief: Rhinomed Seeks Trading Halt